Literature DB >> 24696363

HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research.

Lucette A Cysique1, Robert K Heaton, Jody Kamminga, Tammy Lane, Thomas M Gates, Danielle M Moore, Emma Hubner, Andrew Carr, Bruce J Brew.   

Abstract

The Australian HIV-infected (HIV+) population is largely comprised of high-functioning men who have sex with men (MSM). Like other English-speaking countries, Australia mostly relies on US neuropsychological normative standards to detect and determine the prevalence of neurological disorders. Whether the US neuropsychological (NP) normative standards are appropriate in Australian HIV+ MSM has not been established. Ninety virally suppressed HIV+ and 49 HIV-uninfected (HIV-) men (respectively 86 and 85 % self-reported MSM; mean age 54 and 56 years, mean premorbid verbal IQ estimate 110 and 111) undertook standard NP testing. The raw neuropsychological data were transformed using the following: (1) US standards as uncorrected scaled scores and demographically corrected T scores (US norms); and (2) z scores (without demographic corrections) derived from Australian comparison group scaled scores (local norms). To determine HIV-associated neurocognitive disorder prevalence, we used a standard definition of impairment based upon a battery-wide summary score: the global deficit score (GDS). Impairment classification (GDS ≥ 0.5) based on the local norms was best at discriminating between the two groups (HIV- = 14.3 % vs. HIV+ = 53.3 %; p < 0.0001). This definition was significantly associated with age. Impairment classification based on the US norms yielded much lower impairment rate regardless of the HIV status (HIV- = 4.1 % vs. HIV+ = 14.7 %; p = 0.05), but was associated with historical AIDS, and not age. Both types of summary scores were associated with reduced independence in activities of daily living (p ≤ 0.03). Accurate neuropsychological classifications of high (or low) functioning individuals may need country-specific norms that correct for performance-based (e.g., reading) estimates of premorbid cognition in addition to the traditional demographic factors.

Entities:  

Mesh:

Year:  2014        PMID: 24696363      PMCID: PMC4268870          DOI: 10.1007/s13365-014-0242-x

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  25 in total

1.  Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment.

Authors:  M J Taylor; R K Heaton
Journal:  J Int Neuropsychol Soc       Date:  2001-11       Impact factor: 2.892

2.  Acculturation, reading level, and neuropsychological test performance among African American elders.

Authors:  Jennifer J Manly; Desiree A Byrd; Pegah Touradji; Yaakov Stern
Journal:  Appl Neuropsychol       Date:  2004

3.  Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.

Authors:  Catherine L Carey; Steven Paul Woods; Raul Gonzalez; Emily Conover; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-05       Impact factor: 2.475

4.  Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals.

Authors:  M A Cole; J B Margolick; C Cox; X Li; O A Selnes; E M Martin; J T Becker; H A Aronow; B Cohen; N Sacktor; E N Miller
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

5.  Updated research nosology for HIV-associated neurocognitive disorders.

Authors:  A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

6.  The impact of HIV-associated neuropsychological impairment on everyday functioning.

Authors:  Robert K Heaton; Thomas D Marcotte; Monica Rivera Mindt; Joseph Sadek; David J Moore; Heather Bentley; J Allen McCutchan; Carla Reicks; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2004-05       Impact factor: 2.892

7.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

8.  Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.

Authors:  Jose A Muñoz-Moreno; Carmina R Fumaz; Maria J Ferrer; Anna Prats; Eugènia Negredo; Maite Garolera; Núria Pérez-Alvarez; José Moltó; Guadalupe Gómez; Bonaventura Clotet
Journal:  AIDS Res Hum Retroviruses       Date:  2008-10       Impact factor: 2.205

Review 9.  Validity of cognitive screens for HIV-associated neurocognitive disorder: a systematic review and an informed screen selection guide.

Authors:  Jody Kamminga; Lucette A Cysique; Grace Lu; Jennifer Batchelor; Bruce J Brew
Journal:  Curr HIV/AIDS Rep       Date:  2013-12       Impact factor: 5.071

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more
  32 in total

1.  Empiric neurocognitive performance profile discovery and interpretation in HIV infection.

Authors:  Daniela Gomez; Christopher Power; M John Gill; Noshin Koenig; Roberto Vega; Esther Fujiwara
Journal:  J Neurovirol       Date:  2018-12-05       Impact factor: 2.643

2.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

3.  Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting.

Authors:  Nirupama Yechoor; Sheri L Towe; Kevin R Robertson; Daniel Westreich; Noeline Nakasujja; Christina S Meade
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

4.  Compensatory activation in fronto-parietal cortices among HIV-infected persons during a monetary decision-making task.

Authors:  Christina S Meade; Daniella M Cordero; Andrea L Hobkirk; Brandon M Metra; Nan-Kuei Chen; Scott A Huettel
Journal:  Hum Brain Mapp       Date:  2016-03-23       Impact factor: 5.038

5.  A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review.

Authors:  Mark Bloch; Jody Kamminga; Avindra Jayewardene; Michael Bailey; Angela Carberry; Trina Vincent; Dick Quan; Paul Maruff; Bruce Brew; Lucette A Cysique
Journal:  Clin Infect Dis       Date:  2016-06-19       Impact factor: 9.079

6.  Measures of Physical and Mental Independence Among HIV-Positive Individuals: Impact of Substance Use Disorder.

Authors:  Bianca Christensen; Zijian Qin; Desiree A Byrd; Fang Yu; Susan Morgello; Benjamin B Gelman; David J Moore; Igor Grant; Elyse J Singer; Howard S Fox; Lorena Baccaglini
Journal:  AIDS Res Hum Retroviruses       Date:  2017-04-10       Impact factor: 2.205

7.  Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.

Authors:  Lucette A Cysique; Bruce J Brew
Journal:  J Neurovirol       Date:  2019-01-11       Impact factor: 2.643

8.  Cognitive Burden of Common Non-antiretroviral Medications in HIV-Infected Women.

Authors:  Leah H Rubin; Kendra K Radtke; Seenae Eum; Bani Tamraz; Krithika N Kumanan; Gayle Springer; Pauline M Maki; Kathryn Anastos; Daniel Merenstein; Roksana Karim; Kathleen M Weber; Deborah Gustafson; Ruth M Greenblatt; Jeffrey R Bishop
Journal:  J Acquir Immune Defic Syndr       Date:  2018-09-01       Impact factor: 3.731

9.  Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study.

Authors:  Leah H Rubin; Lorie Benning; Sheila M Keating; Philip J Norris; Jane Burke-Miller; Antonia Savarese; Krithika N Kumanan; Saria Awadalla; Gayle Springer; Kathyrn Anastos; Mary Young; Joel Milam; Victor G Valcour; Kathleen M Weber; Pauline M Maki
Journal:  J Neurovirol       Date:  2017-10-23       Impact factor: 2.643

10.  The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults.

Authors:  Lucette A Cysique; Nadene Dermody; Andrew Carr; Bruce J Brew; Maree Teesson
Journal:  J Neurovirol       Date:  2015-08-25       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.